The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Preclinical In-vivo Imaging Market Research Report 2025
Synopsis
It can reflect the spatial and temporal distribution of cell or gene expression, so as to understand relevant biological processes, specific gene functions and interactions in living animals.
The global Preclinical In-vivo Imaging market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Preclinical In-vivo Imaging is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Preclinical In-vivo Imaging is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Preclinical In-vivo Imaging in Research & Development is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Preclinical In-vivo Imaging include Bruker, Siemens, TriFoil Imaging, PerkinElmer, Fujifilm VisualSonics, MILabs and Mediso, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Preclinical In-vivo Imaging, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Preclinical In-vivo Imaging.
Report Scope
The Preclinical In-vivo Imaging market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Preclinical In-vivo Imaging market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Preclinical In-vivo Imaging companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bruker
Siemens
TriFoil Imaging
PerkinElmer
Fujifilm VisualSonics
MILabs
Mediso
Segment by Type
Optical Imaging Systems
Micro-Ultrasound Systems
Preclinical Nuclear Imaging Systems
Other
Segment by Application
Research & Development
Drug Discovery
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Preclinical In-vivo Imaging companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
It can reflect the spatial and temporal distribution of cell or gene expression, so as to understand relevant biological processes, specific gene functions and interactions in living animals.
The global Preclinical In-vivo Imaging market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Preclinical In-vivo Imaging is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Preclinical In-vivo Imaging is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Preclinical In-vivo Imaging in Research & Development is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Preclinical In-vivo Imaging include Bruker, Siemens, TriFoil Imaging, PerkinElmer, Fujifilm VisualSonics, MILabs and Mediso, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Preclinical In-vivo Imaging, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Preclinical In-vivo Imaging.
Report Scope
The Preclinical In-vivo Imaging market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Preclinical In-vivo Imaging market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Preclinical In-vivo Imaging companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bruker
Siemens
TriFoil Imaging
PerkinElmer
Fujifilm VisualSonics
MILabs
Mediso
Segment by Type
Optical Imaging Systems
Micro-Ultrasound Systems
Preclinical Nuclear Imaging Systems
Other
Segment by Application
Research & Development
Drug Discovery
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Preclinical In-vivo Imaging companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Preclinical In-vivo Imaging Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Optical Imaging Systems
1.2.3 Micro-Ultrasound Systems
1.2.4 Preclinical Nuclear Imaging Systems
1.2.5 Other
1.3 Market by Application
1.3.1 Global Preclinical In-vivo Imaging Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Research & Development
1.3.3 Drug Discovery
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Preclinical In-vivo Imaging Market Perspective (2019-2030)
2.2 Preclinical In-vivo Imaging Growth Trends by Region
2.2.1 Global Preclinical In-vivo Imaging Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Preclinical In-vivo Imaging Historic Market Size by Region (2019-2024)
2.2.3 Preclinical In-vivo Imaging Forecasted Market Size by Region (2025-2030)
2.3 Preclinical In-vivo Imaging Market Dynamics
2.3.1 Preclinical In-vivo Imaging Industry Trends
2.3.2 Preclinical In-vivo Imaging Market Drivers
2.3.3 Preclinical In-vivo Imaging Market Challenges
2.3.4 Preclinical In-vivo Imaging Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Preclinical In-vivo Imaging Players by Revenue
3.1.1 Global Top Preclinical In-vivo Imaging Players by Revenue (2019-2024)
3.1.2 Global Preclinical In-vivo Imaging Revenue Market Share by Players (2019-2024)
3.2 Global Preclinical In-vivo Imaging Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Preclinical In-vivo Imaging Revenue
3.4 Global Preclinical In-vivo Imaging Market Concentration Ratio
3.4.1 Global Preclinical In-vivo Imaging Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Preclinical In-vivo Imaging Revenue in 2023
3.5 Preclinical In-vivo Imaging Key Players Head office and Area Served
3.6 Key Players Preclinical In-vivo Imaging Product Solution and Service
3.7 Date of Enter into Preclinical In-vivo Imaging Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Preclinical In-vivo Imaging Breakdown Data by Type
4.1 Global Preclinical In-vivo Imaging Historic Market Size by Type (2019-2024)
4.2 Global Preclinical In-vivo Imaging Forecasted Market Size by Type (2025-2030)
5 Preclinical In-vivo Imaging Breakdown Data by Application
5.1 Global Preclinical In-vivo Imaging Historic Market Size by Application (2019-2024)
5.2 Global Preclinical In-vivo Imaging Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Preclinical In-vivo Imaging Market Size (2019-2030)
6.2 North America Preclinical In-vivo Imaging Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Preclinical In-vivo Imaging Market Size by Country (2019-2024)
6.4 North America Preclinical In-vivo Imaging Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Preclinical In-vivo Imaging Market Size (2019-2030)
7.2 Europe Preclinical In-vivo Imaging Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Preclinical In-vivo Imaging Market Size by Country (2019-2024)
7.4 Europe Preclinical In-vivo Imaging Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Preclinical In-vivo Imaging Market Size (2019-2030)
8.2 Asia-Pacific Preclinical In-vivo Imaging Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Preclinical In-vivo Imaging Market Size by Region (2019-2024)
8.4 Asia-Pacific Preclinical In-vivo Imaging Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Preclinical In-vivo Imaging Market Size (2019-2030)
9.2 Latin America Preclinical In-vivo Imaging Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Preclinical In-vivo Imaging Market Size by Country (2019-2024)
9.4 Latin America Preclinical In-vivo Imaging Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Preclinical In-vivo Imaging Market Size (2019-2030)
10.2 Middle East & Africa Preclinical In-vivo Imaging Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Preclinical In-vivo Imaging Market Size by Country (2019-2024)
10.4 Middle East & Africa Preclinical In-vivo Imaging Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bruker
11.1.1 Bruker Company Detail
11.1.2 Bruker Business Overview
11.1.3 Bruker Preclinical In-vivo Imaging Introduction
11.1.4 Bruker Revenue in Preclinical In-vivo Imaging Business (2019-2024)
11.1.5 Bruker Recent Development
11.2 Siemens
11.2.1 Siemens Company Detail
11.2.2 Siemens Business Overview
11.2.3 Siemens Preclinical In-vivo Imaging Introduction
11.2.4 Siemens Revenue in Preclinical In-vivo Imaging Business (2019-2024)
11.2.5 Siemens Recent Development
11.3 TriFoil Imaging
11.3.1 TriFoil Imaging Company Detail
11.3.2 TriFoil Imaging Business Overview
11.3.3 TriFoil Imaging Preclinical In-vivo Imaging Introduction
11.3.4 TriFoil Imaging Revenue in Preclinical In-vivo Imaging Business (2019-2024)
11.3.5 TriFoil Imaging Recent Development
11.4 PerkinElmer
11.4.1 PerkinElmer Company Detail
11.4.2 PerkinElmer Business Overview
11.4.3 PerkinElmer Preclinical In-vivo Imaging Introduction
11.4.4 PerkinElmer Revenue in Preclinical In-vivo Imaging Business (2019-2024)
11.4.5 PerkinElmer Recent Development
11.5 Fujifilm VisualSonics
11.5.1 Fujifilm VisualSonics Company Detail
11.5.2 Fujifilm VisualSonics Business Overview
11.5.3 Fujifilm VisualSonics Preclinical In-vivo Imaging Introduction
11.5.4 Fujifilm VisualSonics Revenue in Preclinical In-vivo Imaging Business (2019-2024)
11.5.5 Fujifilm VisualSonics Recent Development
11.6 MILabs
11.6.1 MILabs Company Detail
11.6.2 MILabs Business Overview
11.6.3 MILabs Preclinical In-vivo Imaging Introduction
11.6.4 MILabs Revenue in Preclinical In-vivo Imaging Business (2019-2024)
11.6.5 MILabs Recent Development
11.7 Mediso
11.7.1 Mediso Company Detail
11.7.2 Mediso Business Overview
11.7.3 Mediso Preclinical In-vivo Imaging Introduction
11.7.4 Mediso Revenue in Preclinical In-vivo Imaging Business (2019-2024)
11.7.5 Mediso Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
